ISA Pharmaceuticals´ Chief Scientific Officer Prof. Cornelis Melief Receives ESMO Immuno-Oncology Award 2018

ISA Pharmaceuticals Reports Publication of Favorable Phase 2 Results of ISA101 plus Nivolumab in JAMA Oncology

ISA Pharmaceuticals Promotes Gerben Moolhuizen to Chief Executive Officer

ISA Pharmaceuticals Appoints Leon Hooftman as Chief Medical Officer

ISA Pharmaceuticals’ ISA101 Studied in Phase II Oropharyngeal Cancer Combination Trial at MD Anderson Cancer Center

ISA Pharmaceuticals and Scancell enter collaboration agreement for the manufacturing, development and commercialisation of Modi-1 / AMPLIVANT® combination

ISA Pharmaceuticals to Present at the Biotech Showcase™ Annual Conference 2018